Full article ">Figure 1
<p>Oleanolic acid (<b>OA</b>, <b>1</b>).</p> Full article ">Figure 2
<p>Cytotoxic activity of <b>OA</b> (<b>1</b>), their derivatives and Tamoxifen (100 µM) against the HCT-116, LS-174T and HEK-293 cancer cell lines. Different letters (<b>a</b>–<b>j</b>) indicate significant differences according to Tukey’s test (<span class="html-italic">p</span> ≤ 0.05).</p> Full article ">Figure 3
<p>Principal component analysis “loading plot” of biological activities (anti-inflammatory activity: anti-15-LOX), (antidiabetic activity: anti-α-glucosidase) and the cytotoxic activity (HCT-116, LS-174T and HEK-293) of the new derivatives of <b>OA</b> (<b>1</b>).</p> Full article ">Figure 4
<p>Principal component analysis (PCA) “Biplot” of derivatives and biological activities (anti-inflammatory activity: anti-15-LOX); (antidiabetic activity: anti-<span class="html-italic">α</span>-glucosidase); (cytotoxic activity: HCT-116, LS-174T and HEK-293).</p> Full article ">Scheme 1
<p>Synthetic pathways of <b>4a</b>–<b>n</b> and <b>5a</b>–<b>f</b> derivatives of <b>OA</b>.</p> Full article ">